// AST – IMS - [DMinute_ROS]

As Danaher (DHR) Market Valuation Declined, Shareholder Norris Perne & French Llp Has Upped Its Holding; As Dexcom (DXCM) Stock Declined, Bnp Paribas Investment Partners Sa Decreased Stake

DexCom, Inc. (NASDAQ:DXCM) Logo

Bnp Paribas Investment Partners Sa decreased its stake in Dexcom Inc (DXCM) by 42.3% based on its latest 2018Q3 regulatory filing with the SEC. Bnp Paribas Investment Partners Sa sold 175,414 shares as the company’s stock declined 14.95% with the market. The institutional investor held 239,272 shares of the health care company at the end of 2018Q3, valued at $34.23M, down from 414,686 at the end of the previous reported quarter. Bnp Paribas Investment Partners Sa who had been investing in Dexcom Inc for a number of months, seems to be less bullish one the $12.63B market cap company. The stock increased 0.73% or $1.03 during the last trading session, reaching $142.13. About 425,627 shares traded. DexCom, Inc. (NASDAQ:DXCM) has risen 105.85% since January 14, 2018 and is uptrending. It has outperformed by 105.85% the S&P500. Some Historical DXCM News: 08/03/2018 – WAVEFORM: PTAB UPHOLDS PATENTS CHALLENGED BY DEXCOM; 02/05/2018 – DexCom 1Q Loss/Shr 28c; 02/05/2018 – DEXCOM 1Q LOSS/SHR 28C, EST. LOSS/SHR 33C; 27/03/2018 – U.S. FDA SAYS AUTHORIZATION OF ICGM SYSTEM CLASSIFIES THIS NEW TYPE OF DEVICE IN CLASS Il & SUBJECTS IT TO CERTAIN CRITERIA CALLED SPECIAL CONTROLS; 02/05/2018 – DexCom 1Q Rev $184.4M; 21/03/2018 – ClinicalTrial US: Dexcom G4 in a Population With Normal Oral Glucose Tolerance Test; 29/03/2018 – Alger Spectra Adds DexCom, Cuts CBS, Buys More Facebook; 27/03/2018 – DEXCOM G6 ICGM CAN BE USED TO DETERMINE BLOOD GLUCOSE LEVELS; 27/03/2018 – U.S. FDA SAYS PERMITTED MARKETING OF THE DEXCOM G6 INTEGRATED CONTINUOUS GLUCOSE MONITORING (ICGM) SYSTEM; 09/04/2018 – DexCom Forms Golden Cross: Technicals

Norris Perne & French Llp increased its stake in Danaher Corp (DHR) by 3.92% based on its latest 2018Q3 regulatory filing with the SEC. Norris Perne & French Llp bought 4,287 shares as the company’s stock declined 3.24% with the market. The institutional investor held 113,665 shares of the industrial machinery and components company at the end of 2018Q3, valued at $12.35 million, up from 109,378 at the end of the previous reported quarter. Norris Perne & French Llp who had been investing in Danaher Corp for a number of months, seems to be bullish on the $73.31 billion market cap company. The stock decreased 0.64% or $0.67 during the last trading session, reaching $104.59. About 473,777 shares traded. Danaher Corporation (NYSE:DHR) has risen 9.75% since January 14, 2018 and is uptrending. It has outperformed by 9.75% the S&P500. Some Historical DHR News: 07/03/2018 – Danaher Provides Update on 1Q 2018 Fincl Performance; 16/05/2018 – Danaher at Bernstein Strategic Decisions CEO Conference May 31; 19/04/2018 – Danaher 1Q Adj EPS 99c; 09/03/2018 – Danaher Sees Integrated DNA Deal Closing in Mid-2018; 17/04/2018 – Danaher Corp expected to post earnings of 94 cents a share – Earnings Preview; 25/04/2018 – Danaher Approached GE About Deal for GE’s Life-Sciences Unit; 25/04/2018 – DANAHER APPROACHED GE ABOUT DEAL FOR GE’S LIFE-SCIENCES UNIT – WSJ, CITING; 07/03/2018 – Danaher: Better-Than-Expected Results in Life Sciences, Diagnostics Platforms; 19/04/2018 – Danaher Had Seen 2018 Adjusted EPS $4.25-$4.35; 23/04/2018 – Orthodontic Supplies Market to Hit 8.9% CAGR to 2023, Led by Align Technology, Inc. (US), 3M Company (US), and Danaher Corporation (US)

Since July 16, 2018, it had 0 insider purchases, and 43 sales for $37.65 million activity. $1.48M worth of stock was sold by MOY JEFFREY on Monday, September 10. Blackford Quentin S. sold $1.24 million worth of stock or 8,440 shares. DOUBLEDAY RICHARD had sold 1,736 shares worth $223,466. The insider Balo Andrew K sold 5,000 shares worth $621,253. Murphy Patrick Michael sold $340,825 worth of stock or 2,372 shares. $682,359 worth of stock was sold by ALTMAN STEVEN R on Friday, August 24.

Investors sentiment increased to 1.31 in 2018 Q3. Its up 0.09, from 1.22 in 2018Q2. It increased, as 12 investors sold DXCM shares while 107 reduced holdings. 84 funds opened positions while 72 raised stakes. 84.12 million shares or 4.99% less from 88.54 million shares in 2018Q2 were reported. Amundi Pioneer Asset Mgmt stated it has 0.03% in DexCom, Inc. (NASDAQ:DXCM). The Germany-based Deutsche Fincl Bank Ag has invested 0.06% in DexCom, Inc. (NASDAQ:DXCM). Glenmede Trust Na accumulated 32 shares. Millennium Management Limited Liability invested 0.23% in DexCom, Inc. (NASDAQ:DXCM). Franklin Res invested in 443,523 shares or 0.03% of the stock. Renaissance Techs Ltd Com holds 0.09% in DexCom, Inc. (NASDAQ:DXCM) or 583,059 shares. Alps Advsr Incorporated invested in 3,571 shares. Dafna Mgmt Ltd Co holds 37,000 shares. Castleark Management Lc reported 213,953 shares or 0.88% of all its holdings. Qs Invsts holds 0% or 2,207 shares in its portfolio. Panagora Asset Management Incorporated, Massachusetts-based fund reported 2,050 shares. Arrowmark Colorado Hldgs Llc accumulated 378,886 shares or 0.45% of the stock. Domini Impact Lc accumulated 3,598 shares. Captrust Advisors holds 25 shares. Tocqueville Asset Lp invested in 0.02% or 8,900 shares.

Among 28 analysts covering Dexcom (NASDAQ:DXCM), 21 have Buy rating, 0 Sell and 7 Hold. Therefore 75% are positive. Dexcom had 97 analyst reports since August 6, 2015 according to SRatingsIntel. BMO Capital Markets maintained DexCom, Inc. (NASDAQ:DXCM) on Wednesday, January 17 with “Buy” rating. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Buy” rating by Berenberg on Monday, August 6. The stock of DexCom, Inc. (NASDAQ:DXCM) has “Buy” rating given on Wednesday, February 24 by Jefferies. BMO Capital Markets maintained the shares of DXCM in report on Wednesday, March 28 with “Buy” rating. Canaccord Genuity maintained it with “Buy” rating and $7100 target in Wednesday, March 28 report. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Overweight” rating by JP Morgan on Thursday, September 17. Jefferies maintained DexCom, Inc. (NASDAQ:DXCM) on Wednesday, September 27 with “Buy” rating. Oppenheimer maintained the stock with “Buy” rating in Monday, February 12 report. As per Thursday, November 2, the company rating was maintained by Canaccord Genuity. The stock of DexCom, Inc. (NASDAQ:DXCM) earned “Buy” rating by Oppenheimer on Wednesday, August 2.

More notable recent DexCom, Inc. (NASDAQ:DXCM) news were published by: Nasdaq.com which released: “Here’s Why Tandem Diabetes Care Is Dropping Today – Nasdaq” on January 02, 2019, also Seekingalpha.com with their article: “The Best Performing Stocks Of 2018 – Seeking Alpha” published on January 03, 2019, Nasdaq.com published: “Noteworthy ETF Inflows: FXH, I, HCA, DXCM – Nasdaq” on November 20, 2018. More interesting news about DexCom, Inc. (NASDAQ:DXCM) were released by: Seekingalpha.com and their article: “DexCom Is Priced For Perfection – Seeking Alpha” published on November 21, 2018 as well as Nasdaq.com‘s news article titled: “Strange: Bullish DXCM Analysts Actually See -2.12% Downside – Nasdaq” with publication date: September 17, 2018.

Bnp Paribas Investment Partners Sa, which manages about $13.02 billion US Long portfolio, upped its stake in Lululemon Athletica Inc (NASDAQ:LULU) by 8,915 shares to 117,755 shares, valued at $19.13M in 2018Q3, according to the filing. It also increased its holding in Masimo Corp (NASDAQ:MASI) by 160,317 shares in the quarter, for a total of 354,556 shares, and has risen its stake in Amicus Therapeutics Inc (NASDAQ:FOLD).

Analysts await DexCom, Inc. (NASDAQ:DXCM) to report earnings on February, 26. They expect $0.13 EPS, up 30.00% or $0.03 from last year’s $0.1 per share. DXCM’s profit will be $11.55 million for 273.33 P/E if the $0.13 EPS becomes a reality. After $0.17 actual EPS reported by DexCom, Inc. for the previous quarter, Wall Street now forecasts -23.53% negative EPS growth.

Norris Perne & French Llp, which manages about $1.06B and $763.96 million US Long portfolio, decreased its stake in Berkshire Hathaway Inc Del Cl A (BRKA) by 1 shares to 19 shares, valued at $6.08M in 2018Q3, according to the filing. It also reduced its holding in Middleby Corp (NASDAQ:MIDD) by 3,298 shares in the quarter, leaving it with 54,622 shares, and cut its stake in Boeing Co Com (NYSE:BA).

More news for Danaher Corporation (NYSE:DHR) were recently published by: Seekingalpha.com, which released: “Danaher Q4 revenue growth above guidance – Seeking Alpha” on January 08, 2019. Fool.com‘s article titled: “Forget 3M: GE Is a Better-Value Stock – The Motley Fool” and published on December 28, 2018 is yet another important article.

Investors sentiment increased to 1.22 in 2018 Q3. Its up 0.16, from 1.06 in 2018Q2. It is positive, as 26 investors sold DHR shares while 346 reduced holdings. 97 funds opened positions while 357 raised stakes. 513.23 million shares or 0.85% less from 517.64 million shares in 2018Q2 were reported. Mechanics Financial Bank Tru Department reported 0.09% stake. Tower Bridge Advsrs owns 76,422 shares. Reliance Tru Of Delaware accumulated 4,926 shares. Pictet & Cie (Europe) Sa holds 1.08% in Danaher Corporation (NYSE:DHR) or 70,710 shares. Bryn Mawr Trust Company has invested 0.03% of its portfolio in Danaher Corporation (NYSE:DHR). Signaturefd Lc has invested 0.07% in Danaher Corporation (NYSE:DHR). Element Capital Mgmt Limited Liability Corp accumulated 215,297 shares or 0.47% of the stock. Creative Planning invested in 0.01% or 32,585 shares. Abner Herrman & Brock Ltd holds 0.05% or 3,216 shares in its portfolio. Braun Stacey Assocs Inc invested in 133,773 shares. Scotia Inc reported 0.08% of its portfolio in Danaher Corporation (NYSE:DHR). Stone Ridge Asset Management Ltd Liability Corp holds 0.03% of its portfolio in Danaher Corporation (NYSE:DHR) for 5,872 shares. Intl Ca holds 0.62% in Danaher Corporation (NYSE:DHR) or 43,676 shares. Connecticut-based Bradley Foster & Sargent Ct has invested 2.39% in Danaher Corporation (NYSE:DHR). Employees Retirement Of Texas, Texas-based fund reported 27,000 shares.

DexCom, Inc. (NASDAQ:DXCM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.